Correlation Between Sonoma Pharmaceuticals and Durect

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sonoma Pharmaceuticals and Durect at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonoma Pharmaceuticals and Durect into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sonoma Pharmaceuticals and Durect, you can compare the effects of market volatilities on Sonoma Pharmaceuticals and Durect and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonoma Pharmaceuticals with a short position of Durect. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonoma Pharmaceuticals and Durect.

Diversification Opportunities for Sonoma Pharmaceuticals and Durect

0.32
  Correlation Coefficient

Weak diversification

The 3 months correlation between Sonoma and Durect is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Sonoma Pharmaceuticals and Durect in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Durect and Sonoma Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonoma Pharmaceuticals are associated (or correlated) with Durect. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Durect has no effect on the direction of Sonoma Pharmaceuticals i.e., Sonoma Pharmaceuticals and Durect go up and down completely randomly.

Pair Corralation between Sonoma Pharmaceuticals and Durect

Given the investment horizon of 90 days Sonoma Pharmaceuticals is expected to under-perform the Durect. In addition to that, Sonoma Pharmaceuticals is 1.22 times more volatile than Durect. It trades about -0.02 of its total potential returns per unit of risk. Durect is currently generating about 0.01 per unit of volatility. If you would invest  390.00  in Durect on August 24, 2024 and sell it today you would lose (289.00) from holding Durect or give up 74.1% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Sonoma Pharmaceuticals  vs.  Durect

 Performance 
       Timeline  
Sonoma Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sonoma Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Durect 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Durect has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Sonoma Pharmaceuticals and Durect Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sonoma Pharmaceuticals and Durect

The main advantage of trading using opposite Sonoma Pharmaceuticals and Durect positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonoma Pharmaceuticals position performs unexpectedly, Durect can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Durect will offset losses from the drop in Durect's long position.
The idea behind Sonoma Pharmaceuticals and Durect pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital